Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of BRAF mRNA | affects expression | 21346803
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of BRAF mRNA | decreases expression | 12419474
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of BRAF mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of BRAF mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in decreased expression of BRAF mRNA | decreases expression | 19654921
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of BRAF mRNA | decreases expression | 12419474
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of BRAF mRNA | affects expression | 17555576
|
C015329 |
lycopene |
lycopene results in decreased expression of BRAF protein | decreases expression | 17337101
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of BRAF mRNA | affects binding|decreases expression|increases activity | 19710929
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of BRAF mRNA | increases expression | 16705456
|
C471405 |
sorafenib |
sorafenib binds to and results in decreased activity of BRAF protein | affects binding|decreases activity | 16940797
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of BRAF mRNA | affects expression | 17555576
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of BRAF mRNA | decreases expression | 17045167
|
D014638 |
Vanadates |
Vanadates results in increased expression of BRAF protein | increases expression | 17874149
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.64 | 14745880 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.04 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.17 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.82 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.56 | 16434500 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.31 | 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.66 | 15955085 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
4.13 | 10965797 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.94 | 10982225 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.88 | 16835338 12569548 16251483 18414634 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.54 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.31 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.31 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.36 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.28 | 19371607 12928151 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.47 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.16 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.16 | 16206674 16197459 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.16 | 21138602 18351453 17049068 16273361 20065188 19289846 20859285 11161223 19221464 20005174 16873071 18984771 19200415 20135344 19084267 19103187 16818667 18425577 19288272 19115204 18997820 15668708 19410462 16202921 19189210 15565566 19244106 20544844 19059307 18629630 17242785 18855134 20390343 19155303 21152245 19142967 18815881 17440819 19487384 17261762 17893378 19189212 19066611 19011961 18821012 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.16 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.67 | 16813970 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.62 | 15504454 17687452 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.58 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.26 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.96 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.96 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
8.96 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.96 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.96 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
4.85 | 15504454 17687452 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.85 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
9.67 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.67 | 17572228 |
MESH:C535579 |
Cardiofaciocutaneous syndrome |
marker/mechanism |
|
| 16439621 17703371 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.48 | 15738583 19152805 17938729 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.36 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.33 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.33 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.81 | 6135515 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.67 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.88 | 17110522 17681005 15861022 16919318 17333356 16105132 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.88 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.26 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.82 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.69 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.78 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 18718023 |
MESH:D056685 |
Costello Syndrome |
marker/mechanism |
|
| 17703371 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.82 | 9142499 9211117 16925845 9125849 8800419 9664655 10589399 14991402 17551590 9224671 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.09 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.43 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.45 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.82 | 16285004 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.52 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.30 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.30 | 11834606 12594235 18071297 11739529 11461765 11529661 19416960 19923254 16227642 2444490 14986274 10663392 12705907 18713872 17522070 19420014 11421492 11287661 15968718 14550746 14725611 17906064 16781746 19164858 12392966 12540782 16081117 11743745 16109766 12153990 12958197 10915739 19370779 19739265 16485898 10774834 17562736 15619225 19085960 16393943 16177239 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.30 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.19 | 19426721 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.53 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.56 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.16 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.16 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.55 | 19155303 20544844 16202921 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.55 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.62 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.37 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.37 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
13.37 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.27 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.61 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.26 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.58 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.66 | 6392382 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.77 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.04 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.22 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.26 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.92 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.57 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.07 | 18467677 19772884 16221962 19176532 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.77 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.77 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.64 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.23 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.51 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
2.89 | 16076760 11953799 9931084 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.66 | 16093927 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.88 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.52 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.52 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.38 | 19457130 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.42 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.42 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.84 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.95 | 17551590 15992940 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.07 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.23 | 15629191 12587719 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.54 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.54 | 18625569 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.79 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.75 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.87 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.87 | 16331271 16140955 15748426 17217047 16788101 9834237 17301526 19035177 17368321 17339181 19029980 17361223 16766008 17294898 19225113 16823087 12679006 17107899 19075265 19642359 17506722 17649720 16935935 17712046 16891316 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.34 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.19 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.49 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.49 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.49 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.11 | 12969438 16611625 19014921 12587719 19460945 19784758 11587558 16610002 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
4.11 | 11134558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.29 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
marker/mechanism |
|
| 17514646 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
10.88 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
10.88 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.88 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.88 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.57 | 2876786 2876784 6135515 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.62 | 19168569 17306315 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.62 | 18625569 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.12 | 14737004 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.84 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.66 | 11731420 19196722 14580682 16827153 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.64 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.80 | 17453147 |
MESH:D008545 |
Melanoma |
marker/mechanism |
|
| 19282848 21499247 18421705 |
MESH:D008545 |
Melanoma |
|
sorafenib |
5.47 | 18445842 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.47 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.47 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.26 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.64 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.50 | 16940565 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.58 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.11 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.16 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.03 | 15371236 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.99 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.94 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.56 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.53 | 19410462 |
MESH:D009369 |
Neoplasms |
|
lycopene |
8.55 | 17051425 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.55 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.55 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.10 | 19200415 19189210 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.84 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.54 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.54 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.91 | 18514411 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.43 | 17056641 |
MESH:D009634 |
Noonan Syndrome |
marker/mechanism |
|
| 17703371 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.48 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
5.05 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.05 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.74 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.74 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.48 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.75 | 11578682 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.24 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.07 | 16905509 15371236 6392382 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.60 | 11550810 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.15 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
2.15 | 17337101 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.15 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.15 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
9.48 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
9.48 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.39 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.88 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.41 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.16 | 16283617 16116481 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.57 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.76 | 6392382 17453740 16702368 17050553 19834688 15952646 16353154 18709164 16759981 17938729 17548696 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.70 | 17029826 17050553 15504454 16251483 19538983 17976673 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.70 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.70 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.89 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.89 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.12 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.68 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.20 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
marker/mechanism |
|
| 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.06 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.84 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.26 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.48 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
8.48 | 19322015 19429237 11144890 18640142 17306315 15987713 17976673 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.48 | 17572228 8653321 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.40 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.03 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.73 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.36 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.71 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.82 | 17056641 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.59 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.12 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.02 | 16287080 |